Charts

Gainers ZyVersa Therapeutics (NASDAQ:ZVSA) shares increased by 31.4% to $2.14 during Thursday's regular session. As of 13:30 EST, this ...

Gainers DiamondHead Holdings Corp. (NASDAQ: DHHC) shares jumped 104.2% to $21.15. DiamondHead entered into convertible note ...

ERYTECH Provides Business and Financial Update for the Fourth Quarter and Full Year 2022 Combination with Pherecydes announced, intending to create a global leader in extended phage therapies targeting antimicrobial resistant pathogenic bacteria Deep restructuring implemented; team size reduced by approximately 75% since start of 2022Cash and cash equivalents of €38.8 million ($41.5 million) at the end of December 2022 Cambridge, MA (U.S.) and Lyon (France), March 22, 2023 – ERYTECH Pharma (Nasd

Monthly information related to total number of voting rights and shares composing the share capital _February 28, 2023. Article 223-16 of general regulation of French Autorité des Marchés FinanciersLyon – France Listing markets: Euronext Paris from Euronext (Market segment C - ISIN Code: FR0011471135- Symbol: ERYP) & Nasdaq Global Select Market in the United-States (Symbol : ERYP)Website : www.erytech.com DateTotal of shares composing the share capitalTotal of brut (1) voting rightsTotal of net

Gainers Lucira Health (NASDAQ:LHDX) stock increased by 255.5% to $0.5 during Monday's regular session. The current volume of 208.4 ...

Gainers Cingulate (NASDAQ:CING) stock increased by 49.1% to $1.66 during Friday's regular session. Trading volume for Cingulate's stock ...

ERYTECH and PHERECYDES Announce Proposed Combination Intending to Create Global Leader in Extended Phage Therapies Conference call and webcast in English on February 16, 2023at 8:30am EST / 02:30pm CET and in French on the same day at 12pm EST / 6pm CET Strategic combination would build on complementary expertise and capabilities of both companies to accelerate development of extended phage therapies for antimicrobial resistance (AMR), in particular via the phase II PhagoDAIR study conducted by

Monthly information related to total number of voting rights and shares composing the share capital _January 31, 2023. Article 223-16 of general regulation of French Autorité des Marchés FinanciersLyon – France Listing markets: Euronext Paris from Euronext (Market segment C - ISIN Code: FR0011471135- Symbol: ERYP) & Nasdaq Global Select Market in the United-States (Symbol : ERYP)Website : www.erytech.com DateTotal of shares composing the share capitalTotal of brut (1) voting rightsTotal of net (

Gainers Versus Systems Inc. (NASDAQ: VS) surged 270% to $2.26 after the company announced it will partner with Resolve to bring ...

Gainers Bright Green (NASDAQ:BGXX) shares increased by 251.2% to $1.83 during Wednesday's regular session. The current volume of 81.8 ...

Gainers Quoin Pharmaceuticals (NASDAQ:QNRX) stock rose 76.6% to $2.95 during Wednesday's pre-market session. The company's market cap ...

Gainers Motorsport Games Inc. (NASDAQ: MSGM) shares jumped 770% to $22.99. The company announced a debt-for-equity exchange with ...

Gainers Hillstream BioPharma (NASDAQ:HILS) stock rose 95.2% to $1.31 during Tuesday's regular session. As of 12:30 EST, Hillstream ...

Gainers Hillstream BioPharma (NASDAQ:HILS) stock rose 131.0% to $1.55 during Tuesday's pre-market session. The company's market cap ...

Gainers Heart Test Laboratories, Inc. (NASDAQ: HSCS) shares surged 136% to $2.06 after Ascendant Capital initiated coverage on the ...

Gainers Baudax Bio, Inc. (NASDAQ: BXRX) shares surged 59.7% to $5.03 after the company announced the outcome of its first interim ...

Monthly information related to total number of voting rights and shares composing the share capital _December 31, 2022. Article 223-16 of general regulation of French Autorité des Marchés FinanciersLyon – France Listing markets: Euronext Paris from Euronext (Market segment C - ISIN Code: FR0011471135- Symbol: ERYP) & Nasdaq Global Select Market in the United-States (Symbol : ERYP)Website : www.erytech.com DateTotal of shares composing the share capitalTotal of brut (1) voting rightsTotal of net

Monthly information related to total number of voting rights and shares composing the share capital _October 30, 2022. Article 223-16 of general regulation of French Autorité des Marchés FinanciersLyon – France Listing markets: Euronext Paris from Euronext (Market segment C - ISIN Code: FR0011471135- Symbol: ERYP) & Nasdaq Global Select Market in the United-States (Symbol : ERYP)Website : www.erytech.com DateTotal of shares composing the share capitalTotal of brut (1) voting rightsTotal of net (

Monthly information related to total number of voting rights and shares composing the share capital _November 30, 2022. Article 223-16 of general regulation of French Autorité des Marchés FinanciersLyon – France Listing markets: Euronext Paris from Euronext (Market segment C - ISIN Code: FR0011471135- Symbol: ERYP) & Nasdaq Global Select Market in the United-States (Symbol : ERYP)Website : www.erytech.com DateTotal of shares composing the share capitalTotal of brut (1) voting rightsTotal of net

ERYTECH Provides Business and Financial Update for the Third Quarter of 2022 Conference call and webcast on Tuesday, November 22, 2022at 8:30am ET / 02:30pm CET Lead program Graspa halted Focus on preclinical programs and partnering optionsDeep restructuring implemented; team size reduced by approximately 75% since start of year Cash and cash equivalents of €47.3 million ($46.3 million) at the end of September 2022 Cambridge, MA (U.S.) and Lyon (France), November 21, 2022 – ERYTECH Pharma (Nasda

ERYTECH Announces Receipt of Nasdaq Notice Cambridge, MA (U.S.) and Lyon (France), October 13, 2022 – ERYTECH Pharma (Nasdaq & Euronext: a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced that it received written notification (the “Notification Letter”) from The Nasdaq Stock Market LLC ("Nasdaq") dated October 7, 2022, indicating that, based upon a closing bid price of less than $1.00 per

Gainers Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) rose 43.2% to $0.2097 in pre-market trading after jumping over 16% on ...

Gainers FedNat Holding Company (NASDAQ: FNHC) shares climbed 107.7% to close at $0.3395 on Tuesday. DICE Therapeutics, Inc. ...

Erytech Pharma SA Sponsored ADR (ERYP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Monthly information related to total number of voting rights and shares composing the share capital _September 30, 2022. Article 223-16 of general regulation of French Autorité des Marchés FinanciersLyon – France Listing markets: Euronext Paris from Euronext (Market segment C - ISIN Code: FR0011471135- Symbol: ERYP) & Nasdaq Global Select Market in the United-States (Symbol : ERYP)Website : www.erytech.com DateTotal of shares composing the share capitalTotal of brut (1) voting rightsTotal of net

Gainers Spero Therapeutics, Inc. (NASDAQ: SPRO) shares jumped 167.7% to close at $2.20 on Thursday after the company announced it ...

ERYTECH Provides Business and Financial Update for the First Half of 2022 Conference call and webcast on Tuesday, September 13, 2022at 8:30am ET / 02:30pm CEST U.S. cell therapy manufacturing facility sold to Catalent in April 2022Evaluation of partnering options ongoing, strategic initiative expected in Q4 2022Plans to pursue a BLA submission for Graspa® in hypersensitive ALL stopped Cash and cash equivalents of €53.3 million ($55.8 million) at the end of June 2022 Cambridge, MA (U.S.) and Lyon

Companies Reporting Before The Bell • Optical Cable (NASDAQ:OCC) is projected to report earnings for its third ...

Monthly information related to total number of voting rights and shares composing the share capital _July 31, 2022. Article 223-16 of general regulation of French Autorité des Marchés FinanciersLyon – France Listing markets: Euronext Paris from Euronext (Market segment C - ISIN Code: FR0011471135- Symbol: ERYP) & Nasdaq Global Select Market in the United-States (Symbol : ERYP)Website : www.erytech.com DateTotal of shares composing the share capitalTotal of brut (1) voting rightsTotal of net (2)

Monthly information related to total number of voting rights and shares composing the share capital _August 31, 2022. Article 223-16 of general regulation of French Autorité des Marchés FinanciersLyon – France Listing markets: Euronext Paris from Euronext (Market segment C - ISIN Code: FR0011471135- Symbol: ERYP) & Nasdaq Global Select Market in the United-States (Symbol : ERYP)Website : www.erytech.com DateTotal of shares composing the share capitalTotal of brut (1) voting rightsTotal of net (2

After evaluating the FDA's feedback, Erytech Pharma (ERYP) halts developing its lead candidate in leukemia. It is also looking for strategic partnerships to leverage its proprietary platform.

Gainers Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) surged 95.3% to close at $0.2580 on Thursday after Ladenburg Thalmann initiated ...

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 1% on Thursday. The Dow traded up 0.29% ...

Gainers Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) jumped 91% to $0.2530 after Ladenburg Thalmann initiated coverage on the stock ...

On Thursday,63 companies set new 52-week lows. Areas of Interest About Today's 52-Week Lows: Sanofi ...

U.S. stocks traded higher midway through trading, with the Nasdaq Composite adding around 100 points on Thursday. The Dow traded up ...

Gainers Kiora Pharmaceuticals (NASDAQ:KPRX) shares moved upwards by 62.8% to $0.21 during Thursday's pre-market ...

Erytech Pharma SA(NASDAQ: ERYP)will no longer seek approvalfor Graspa in hypersensitive acute lymphoblastic ...

Gainers Aridis Pharmaceuticals (NASDAQ:ARDS) shares moved upwards by 20.1% to $1.79 during Wednesday's after-market session. The ...

ERYTECH Provides Regulatory Update ERYTECH to stop further plans to pursue a BLA submission seeking an approval for Graspa® in hypersensitive ALLEvaluation of strategic partnering options ongoing Cambridge, MA (U.S.) and Lyon (France), August 24, 2022 – ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today provided a regulatory update, announcing that it is no

Monthly information related to total number of voting rights and shares composing the share capital _June 30, 2022. Article 223-16 of general regulation of French Autorité des Marchés FinanciersLyon – France Listing markets: Euronext Paris from Euronext (Market segment C - ISIN Code: FR0011471135- Symbol: ERYP) & Nasdaq Global Select Market in the United-States (Symbol : ERYP)Website : www.erytech.com DateTotal of shares composing the share capitalTotal of brut (1) voting rightsTotal of net (2)

REPORT – ERYTECH’S COMBINED SHAREHOLDERS’ MEETING ON JUNE 24, 2022 Cambridge, MA (U.S.) and Lyon (France), June 24, 2022 – ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced that its Annual General Meeting was held on Friday, June 24, 2022. At the meeting, all resolutions for which the Board of Directors recommended a vote in favor were adopted, i

Monthly information related to total number of voting rights and shares composing the share capital _May 31, 2022. Article 223-16 of general regulation of French Autorité des Marchés FinanciersLyon – France Listing markets: Euronext Paris from Euronext (Market segment C - ISIN Code: FR0011471135- Symbol: ERYP) & Nasdaq Global Select Market in the United-States (Symbol : ERYP)Website : www.erytech.com DateTotal of shares composing the share capitalTotal of brut (1) voting rightsTotal of net (2) v

Gainers Evoke Pharma, Inc. (NASDAQ: EVOK) shares jumped 118.5% to close at $0.86 on Tuesday. The FDA granted new drug product ...

Gainers Avadel Pharmaceuticals plc. (NASDAQ: AVDL) shares gained 36.3% to $5.74. Shares closed down 36% on Monday, seemingly on no ...

Gainers Q&K International Group Limited (NASDAQ: QK) shares rose 59.2% to $1.56 in pre-market trading after dropping around 5% ...

Gainers Nkarta, Inc. (NASDAQ: NKTX) shares climbed 140.9% to close at $18.72 on Monday after the company announced Phase 1 data ...

Gainers Avadel Pharmaceuticals (NASDAQ:AVDL) stock moved upwards by 30.6% to $5.5 during Monday's after-market session. This security ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Today, investors are pricing in a massive divestiture and long-term supply deal into the valuation of ERYTECH and ERYP stock. The post Why Is ERYTECH Pharma (ERYP) Stock Up Today? appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS It doesn’t matter if you have $500 in savings or $5 million. Do this now. Get in Now on Tiny $3 ‘Forever Battery’ Stock Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”

Gainers Nkarta, Inc. (NASDAQ: NKTX) shares jumped 108.6% to $16.21 after the company announced Phase 1 data from independent dose ...

Gainers Erytech Pharma (NASDAQ:ERYP) stock rose 52.5% to $1.86 during Monday's pre-market session. The company's ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Another day of investing awaits for traders as we start it off with a breakdown of the biggest pre-market stock movers for Monday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS It doesn’t matter if you have $500 in savings or $5 million. Do this now. Get in Now on Tiny $3 ‘Forever Battery’ Stock Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”

Erytech Pharma SA(NASDAQ: ERYP) has sold its US manufacturing facility toCatalent Inc(NYSE: CTLT)for $44.5 ...

Gainers ERYTECH Pharma S.A. (NASDAQ: ERYP) shares rose 88.4% to $2.30 in pre-market trading. Erytech Pharma recently announced ...

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus AstraZeneca In-Licenses ...

Erytech Pharma SA(NASDAQ: ERYP) says that the results from the NOPHO sponsored Phase 2 trial of eryaspase in acute ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips We're diving into the biggest pre-market stock movers for Thursday that investors are going to want to keep track of today. The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS It doesn’t matter if you have $500 in savings or $5 million. Do this now. 10 Stocks Are Issuing Sell Signals Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”

Gainers HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) rose 46.7% to $1.88 in pre-market trading after the company announced it ...